Last 0.40 MYR
Change Today 0.00 / 0.00%
Volume 10.0K
MGRC On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 11:48 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

malaysian genomics resource (MGRC) Snapshot

Open
0.40
Previous Close
0.40
Day High
0.40
Day Low
0.40
52 Week High
01/2/14 - 0.53
52 Week Low
03/19/14 - 0.36
Market Cap
37.6M
Average Volume 10 Days
18.2K
EPS TTM
-0.06
Shares Outstanding
94.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MALAYSIAN GENOMICS RESOURCE (MGRC)

Related News

No related news articles were found.

malaysian genomics resource (MGRC) Related Businessweek News

No Related Businessweek News Found

malaysian genomics resource (MGRC) Details

Malaysian Genomics Resource Centre Berhad, an investment holding company, provides genome sequencing, bioinformatics analysis, and genetic screening services, as well as online access to genomic data and bioinformatics applications. Its services include sequencing and analysis of various human, animal, plant, and microbial genomes for customers worldwide. The company offers high-throughput sequencing services, including whole genome and transcriptome sequencing, and metagenomics and metatranscriptomics services. It also provides contract genomics services, which comprise reads quality analysis, whole genome assembly, variation analysis of genomes, gene annotation, and exome and transcriptome analysis, as well as other analytical pipelines for processing ChIP-Seq data, annotating and analysing microRNAs, and analysing mutations; trait analysis services to screen multiple samples of previously identified genetic markers within plant and animal genomes; and TRIO sequencing services, which provide a detailed view of an individual’s DNA. In addition, the company offers genetic screening services, such as Dtect, a range of test panels that are designed to screen for genetic markers in an individual’s DNA; Cyto Dtect for screening various genetic loci across the genome; and Gene Dtect that screens patterns of genetic variation within various human genes in the protein coding space. Further, it provides online tools for searching, annotation and mapping, and advanced analysis; and operates a biocomputational center for genomics. Malaysian Genomics Resource Centre Berhad serves research centers, and government and academic institutions and laboratories, as well as pharmaceutical, biotechnology, and agriculture companies. The company was founded in 2004 and is based in Kuala Lumpur, Malaysia. Malaysian Genomics Resource Centre Berhad is a subsidiary of Synamatix Sdn Bhd.

Founded in 2004

malaysian genomics resource (MGRC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

malaysian genomics resource (MGRC) Key Developments

Malaysian Genomics Resource Centre Berhad Announces Unaudited Group Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Malaysian Genomics Resource Centre Berhad announced unaudited group earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, the company reported revenue of MYR 423,000 against MYR 169,000 a year ago. Loss from operations was MYR 2,084,000 against MYR 2,519,000 a year ago. Loss before tax was MYR 1,956,000 against MYR 2,350,000 a year ago. Loss, net of tax, representing total comprehensive income was MYR 1,961,000 against MYR 2,356,000 a year ago. Loss attributable to the owners of the parent company was MYR 1,961,000 or 2.08 sen per basic share against MYR 2,356,000 or 2.50 sen per basic share a year ago. The loss before tax was lower mainly due to higher revenue (MYR 0.4 million for the third quarter ended March 31, 2014 as compared to MYR 0.2 million for the third quarter in the preceding year), waived exclusive license fee and system maintenance cost. For the nine months, the company reported revenue of MYR 2,411,000 against MYR 279,000 a year ago. Loss from operations was MYR 5,161,000 against MYR 7,961,000 a year ago. Loss before tax was MYR 4,516,000 against MYR 7,997,000 a year ago. Loss, net of tax, representing total comprehensive income was MYR 4,536,000 against MYR 8,035,000 a year ago. Loss attributable to the owners of the parent company was MYR 4,536,000 or 4.82 sen per basic share against MYR 8,035,000 or 8.54 sen per basic share a year ago. Net cash used in operating activities was MYR 3,074,000 against net cash generated from operating activities of MYR 986,000 a year ago. Purchase of plant and equipment was MYR 42,000 against MYR 124,000 a year ago. The loss before tax was lower mainly due to higher revenue (MYR 2.4 million compared to MYR 0.3 million), share of profits of jointly controlled entity, waived exclusive license fee and system maintenance cost.

Malaysian Genomics Resource Centre Berhad Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended December 31, 2013

Malaysian Genomics Resource Centre Berhad announced unaudited consolidated earnings results for second quarter and six months ended December 31, 2013. For the quarter, the company reported revenue of MYR 1,383,000 against MYR 52,000 a year ago. Loss from operating was MYR 1,152,000 against MYR 2,681,000 a year ago. Loss before tax was MYR 832,000 against MYR 2,886,000 a year ago. Loss attributable to owners of the parent was MYR 839,000 or 0.89 sen per basic share against MYR 2,897,000 or 3.08 sen per basic share a year ago. For the six months, the company reported revenue of MYR 1,988,000 against MYR 110,000 a year ago. Loss from operating was MYR 3,077,000 against MYR 5,442,000 a year ago. Loss before tax was MYR 2,560,000 against MYR 5,647,000 a year ago. Loss attributable to owners of the parent was MYR 2,575,000 or 2.74 sen per basic share against MYR 2,575,000 or 6.04 sen per basic share a year ago. Net cash used in operating activities was MYR 2,206,000 against MYR 169,000 a year ago. Purchase of plant and equipment was MYR 29,000 against MYR 98,000 a year ago. The loss before taxation was lower mainly due to higher revenue (MYR 2.0 million versus MYR 0.1 million), improved performance of the jointly controlled entity, waived exclusive license fee and system maintenance cost.

Malaysian Genomics Resource Centre Berhad Announces Unaudited Consolidated Earnings Results for First Quarter Ended September 30, 2013

Malaysian Genomics Resource Centre Berhad announced unaudited consolidated earnings results for first quarter ended September 30, 2013. For the quarter, the company reported revenue of MYR 605,000 against MYR 6,084,204 a year ago. Loss from operating was MYR 1,925,000 against MYR 2,761,000 a year ago. Loss before tax was MYR 1,728,000 against MYR 2,761,000 a year ago. Loss attributable to owners of the parent was MYR 1,736,000 or 1.84 sen per basic share against MYR 2,782,000 or 2.96 sen per basic share a year ago. Net cash used in operating activities was MYR 1,253,000 against MYR 2,326,000 a year ago. Purchase of plant and equipment was MYR 24,000 against MYR 92,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MGRC:MK 0.40 MYR 0.00

MGRC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MGRC.
View Industry Companies
 

Industry Analysis

MGRC

Industry Average

Valuation MGRC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.5x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MALAYSIAN GENOMICS RESOURCE, please visit www.mgrc.com.my. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.